Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient.
Gatifloxacin has been reported to cause dysglycaemia, especially in the elderly and in diabetics. In this communication, we describe a case of a non-diabetic renal transplant recipient who came to us in a state of diabetic ketoacidosis following the use of gatifloxacin for a urinary tract infection.
Khaira
Ambar
A
Department of Nephrology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Gupta
Ankur
A
Tandon
Nikhil
N
Agarwal
Sanjay K
SK
D000890:Anti-Infective Agents / Q000009:adverse effects*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000188:drug therapy; D024841:Fluoroquinolones / Q000009:adverse effects*; D000077734:Gatifloxacin; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D007004:Hypoglycemic Agents; D007328:Insulin; D000077734:Gatifloxacin